Previously we discussed how unexpected costs can be generated in the construction of a pharmaceutical plant; in this article we will see the potential and the advantages of BIM technology – Building Information Modeling, which involves three-dimensional and parametric modeling of the whole building, including all its architectural, structural and system information characteristics.
Below the main advantages due to the application of BIM technology, nowadays a fundamental and indispensable tool, in the construction and management of the virtual model of the building-plant system referring to the pharmaceutical sector.
The elaboration and use of a BIM information model and its technology allow to:
The BIM model of the entire building, complete in its architectural, structural and plant components, therefore has many advantages starting from the design phase; however, an additional advantage to consider is the possibility to better manage even the future routine and extraordinary maintenance.
An updated “As-Built” template becomes a powerful tool for the management of the building and its systems because its characteristics and properties are not entrusted only to some technician or maintenance manager but are integrated into the information available to all the company.
Among the advantages that the BIM information model may present during maintenance are the possibility of:
The BIM model is therefore of great help because it guarantees a more detailed knowledge, facilitates the identification of any problems, supports in a more effective way analysis and decision-making processes, the result of which is surely an optimization of the facility management processes and, consequently, also an economic and time saving.
The author is one of the founding partners of the engineering company Planex s.r.l. since 2002 and for over 30 years, has been involved in the engineering processes of pharmaceutical plants and buildings. His career starts in 1989 with the design and construction activities for a new department of freeze-dried injectable products of the Lepetit company, which at the time belonged to the DOW Chemical group, and continues nowadays with the design and construction management of the new production site M. Polo of the Zambon Group, the site Masterplan of an ITALFARMACO S.p.A plant, the creation of a new production department of Fresenjus Kabi S.p.A., various interventions within the EVOTEC Aptuit research center in Verona.
During his career he has also worked on other type of extremely complex buildings; he has taken care of the realization of the new productive site for Pastificio Rana S.p.A. in San Giovanni Lupatoto – Verona, the new Cetacean pavilion for the Aquarium of Genoa, the testing of Isozaki Allianz tower systems in Milan and many more.